EW vs LIEN · P/E 47, rev $1.39B vs P/E 6.5, $223.4M cap
Edwards Lifesciences Corp (EW) versus Chicago Atlantic BDC, Inc. (LIEN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Chicago Atlantic BDC, Inc. (LIEN) is a asset management company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
LIEN does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LIEN currently screens at market cap $223.4M and trailing P/E 6.5.
Not investment advice. Open the EW and LIEN stock pages for the full models.
Not investment advice.